Key Takeaways Thermo Fisher expands pharma, biotech, and biosciences capacity to support global vaccine demand.TMO's new alliances include a Sanofi site acquisition and a Chan Zuckerberg imaging collaboration.Macroeconomic volatility and rising SG&A costs pressured TMO's margins, while competition remained intense.Thermo Fisher Scientific Inc.’s (TMO) recent slew of strategic collaborations reflects its ongoing commitment to sustainable long-term growth. End markets play an important role as well, bolsterin ...